MedTrace Logo

SWedish Intensive Care Biobank

NCT07582601 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 25000

Last updated 2026-05-13

No results posted yet for this study

Summary

The goal of this observational study is to understand the genetic and molecular risk factors for developing critical illness in adult intensive care unit (ICU) patients in Sweden. The main questions it aims to answer are:

Which genetic variants are associated with increased risk of critical illness from conditions such as infections, sepsis, and organ failure?

Can circulating proteins and metabolites mediate the effect of genetic risk factors on the severity of illness?

Participants will:

Provide blood samples at ICU admission and again 3-6 months after discharge Consent to genetic analysis and data linkage with national health registries

Have their ICU treatment and outcomes followed using registry and clinical data

This study aims to build a national infrastructure for rapid sample collection and analysis that can also support research in future pandemics.

Conditions

  • Any Condition Underlying Critical Illness

Sponsors & Collaborators

  • Uppsala University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-01-01
Primary Completion
2035-12-30
Completion
2035-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07582601 on ClinicalTrials.gov